CEFAZIME FOR INJECTION 1 g/vial
Product details
Registration number: SIN11470P
Classification: Prescription Only
Active ingredients:
- CEFTAZIDIME PENTAHYDRATE EQV CEFTAZIDIME
- SODIUM CARBONATE
Strength:
- 1 g/vial
- 121 mg/vial
Dosage form: INJECTION
Route: INTRAVENOUS; INTRAMUSCULAR
Registrant: ZYFAS MEDICAL CO
ATC code: J01DD02
HSA approval date: 26 March 2001
Manufacturer(s): CJ CORP
Manufacturing country/countries: KOREA, REPUBLIC OF
What are the HSA registration number and classification for CEFAZIME FOR INJECTION 1 g/vial?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN11470P
Classification: Prescription Only
What active ingredients and strength are recorded for CEFAZIME FOR INJECTION 1 g/vial?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- CEFTAZIDIME PENTAHYDRATE EQV CEFTAZIDIME
- SODIUM CARBONATE
Strength:
- 1 g/vial
- 121 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for CEFAZIME FOR INJECTION 1 g/vial?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION
Route: INTRAVENOUS; INTRAMUSCULAR
Who is the recorded registrant for CEFAZIME FOR INJECTION 1 g/vial?
According to the HSA dataset updated 7 August 2026:
Registrant: ZYFAS MEDICAL CO
Which manufacturers and countries are listed for CEFAZIME FOR INJECTION 1 g/vial?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): CJ CORP
Manufacturing country/countries: KOREA, REPUBLIC OF
Where can I look up CEFAZIME FOR INJECTION 1 g/vial in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN11470P or the exact product name CEFAZIME FOR INJECTION 1 g/vial. The general register link does not preselect this product.
What are the source dates for this CEFAZIME FOR INJECTION 1 g/vial record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this CEFAZIME FOR INJECTION 1 g/vial record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN11470P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)